Comment diagnostiquer une infection par Alvéolés ?

Le diagnostic se fait par microscopie et tests moléculaires pour identifier les espèces.

Quels tests sont utilisés pour les Alvéolés ?

Des tests sérologiques et des cultures cellulaires peuvent être utilisés pour le diagnostic.

Les Alvéolés peuvent-ils être détectés dans le sang ?

Oui, certains Alvéolés peuvent être détectés dans le sang par des tests spécifiques.

Quels symptômes indiquent une infection par Alvéolés ?

Les symptômes incluent fièvre, diarrhée, et douleurs abdominales selon l'espèce.

Les examens d'imagerie sont-ils utiles ?

Les examens d'imagerie peuvent aider à évaluer les complications, mais ne sont pas spécifiques.

Quels sont les symptômes courants des infections par Alvéolés ?

Les symptômes incluent diarrhée, douleurs abdominales, fatigue et fièvre.

Les Alvéolés provoquent-ils des symptômes respiratoires ?

Certains Alvéolés peuvent causer des symptômes respiratoires, mais c'est rare.

Comment les symptômes varient-ils selon l'espèce ?

Les symptômes varient selon l'espèce d'Alvéolé, certains étant plus virulents que d'autres.

Les symptômes sont-ils immédiats après infection ?

Non, les symptômes peuvent apparaître plusieurs jours après l'infection.

Y a-t-il des symptômes spécifiques aux enfants ?

Les enfants peuvent présenter des symptômes plus graves, comme déshydratation.

Comment prévenir les infections par Alvéolés ?

Maintenir une bonne hygiène, éviter l'eau contaminée et cuire les aliments correctement.

Les vaccins existent-ils pour les Alvéolés ?

Actuellement, il n'existe pas de vaccins spécifiques contre les infections par Alvéolés.

L'eau potable est-elle un risque d'infection ?

Oui, l'eau non traitée peut être une source d'infection par des Alvéolés.

Les voyages augmentent-ils le risque d'infection ?

Oui, voyager dans des zones endommagées augmente le risque d'exposition aux Alvéolés.

Les mesures d'hygiène personnelle sont-elles suffisantes ?

Elles sont essentielles, mais doivent être combinées avec des précautions alimentaires.

Quels traitements sont efficaces contre les Alvéolés ?

Les traitements incluent des antiparasitaires comme le métronidazole ou l'azithromycine.

Les antibiotiques sont-ils utiles contre les Alvéolés ?

Les antibiotiques ne sont généralement pas efficaces contre les infections par Alvéolés.

Comment traiter la déshydratation causée par les Alvéolés ?

La réhydratation orale ou intraveineuse est essentielle pour traiter la déshydratation.

Les traitements sont-ils différents pour les adultes et les enfants ?

Les traitements sont similaires, mais les doses peuvent varier selon l'âge et le poids.

Y a-t-il des traitements préventifs contre les Alvéolés ?

Il n'existe pas de traitements préventifs spécifiques, mais l'hygiène aide à prévenir les infections.

Quelles complications peuvent survenir avec les Alvéolés ?

Les complications incluent la déshydratation sévère, des infections secondaires et des troubles digestifs.

Les Alvéolés peuvent-ils causer des maladies chroniques ?

Certaines infections peuvent entraîner des maladies chroniques si non traitées.

Comment gérer les complications liées aux Alvéolés ?

La gestion inclut un traitement rapide et une surveillance des signes de déshydratation.

Les complications sont-elles fréquentes ?

Les complications sont rares avec un traitement approprié, mais peuvent survenir.

Les personnes immunodéprimées sont-elles à risque ?

Oui, les personnes immunodéprimées sont plus susceptibles de développer des complications graves.

Quels sont les principaux facteurs de risque d'infection par Alvéolés ?

Les facteurs incluent l'immunodépression, le voyage dans des zones endommagées et l'eau contaminée.

Les enfants sont-ils plus à risque ?

Oui, les enfants sont plus vulnérables aux infections par Alvéolés en raison de leur système immunitaire.

Les personnes âgées sont-elles à risque accru ?

Oui, les personnes âgées ont un risque accru en raison de la diminution de leur immunité.

Le mode de vie influence-t-il le risque d'infection ?

Oui, un mode de vie avec de mauvaises pratiques d'hygiène augmente le risque d'infection.

Les maladies préexistantes augmentent-elles le risque ?

Oui, les maladies préexistantes comme le VIH augmentent le risque d'infection par Alvéolés.

Alveolata - Informations médicales vérifiées

Influence of radiotherapy interruption on esophageal cancer with intensity-modulated radiotherapy: a retrospective study.

27 May 2024

DOI: 10.1186/s12885-024-12383-7 PMID: 38802765

Radiotherapy interruption (RTI) prolongs the overall total treatment time and leads to local control loss in many cancers, but it is unclear in esophageal cancer. We aimed to evaluate the influence of... A total of 299 patients with esophageal squamous cell carcinoma from 2017 to 2019 were retrospectively analyzed to investigate the effect of RTI on OS, PFS, and LRFS. The delayed time of radiotherapy ... The 3-year OS, PFS, and LRFS rates were 53.0%, 42.0%, and 48.0%, respectively. The univariate and multivariate analyses showed that the delayed time > 3 days was an independent adverse prognostic fact... There was a significant correlation between delayed time and local control of esophageal cancer. The delayed time for more than 3 days might decrease the survival outcome, and increase the local recur...

Humans Esophageal Neoplasms Retrospective Studies Male Female +12 autres

Online adaptive planning methods for intensity-modulated radiotherapy.

11 05 2023

DOI: 10.1088/1361-6560/accdb2 PMID: 37068488

Online adaptive radiation therapy aims at adapting a patient's treatment plan to their current anatomy to account for inter-fraction variations before daily treatment delivery. As this process needs t...

Humans Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Radiotherapy Dosage Artificial Intelligence

Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial.

08 2023

DOI: 10.1016/S1470-2045(23)00265-6 PMID: 37423227

Most newly diagnosed oropharyngeal and hypopharyngeal cancers are treated with chemoradiotherapy with curative intent but at the consequence of adverse effects on quality of life. We aimed to investig... DARS was a parallel-group, phase 3, multicentre, randomised, controlled trial done in 22 radiotherapy centres in Ireland and the UK. Participants were aged 18 years and older, had T1-4, N0-3, M0 oroph... From June 24, 2016, to April 27, 2018, 118 patients were registered, 112 of whom were randomly assigned (56 to each treatment group). 22 (20%) participants were female and 90 (80%) were male; median a... Our findings suggest that DO-IMRT improves patient-reported swallowing function compared with standard IMRT. DO-IMRT should be considered a new standard of care for patients receiving radiotherapy for... Cancer Research UK....

Humans Male Female Middle Aged Radiotherapy, Intensity-Modulated +4 autres

Racial and Ethnic Health Disparities in Delay to Initiation of Intensity-Modulated Radiotherapy.

10 2022

DOI: 10.1200/OP.22.00104 PMID: 35930751

Delays in initiation of radiotherapy may contribute to inferior oncologic outcomes that are more commonly observed in minoritized populations in the United States. We aimed to examine inequities assoc... The National Cancer Database was queried to identify the 10 cancer sites most commonly treated with IMRT. Interval to initiation of treatment (IIT) was broken into quartiles for each disease site, wit... Among patients (n = 350,425) treated with IMRT between 2004 and 2017, non-Hispanic Black (NHB), Hispanic, and Asian patients were significantly more likely to have delayed IIT with IMRT for nearly all... Delays in initiation of IMRT in NHB, Hispanic, and Asian patients may contribute to the known differences in cancer outcomes and warrant further investigation, particularly to further clarify the role...

Black or African American Aged Hispanic or Latino Humans Medicare +3 autres

Comparative Study of Dysphagia-optimized Intensity Modulated Radiotherapy (Do-IMRT) and Standard Intensity Modulated Radiotherapy (S-IMRT) and Its Clinical Correlation in Head and Neck Cancer Patients.

01 Nov 2023

DOI: 10.31557/APJCP.2023.24.11.3697 PMID: 38019227

Dosimetric sparing of critical swallowing structures like constrictor muscles and larynx can lead to improved functional outcomes in head and neck cancer patients treated by chemoradiation.... A total of 50 Patients with newly diagnosed, biopsy proven AJCC stage II-IV head and neck squamous cell cancers (HNSCC) were prospectively studied. 25 patients were randomized in each arm of Dysphagia... Patients in both arms showed significant (P <0.01 or P < 0.001) improvement in MDADI (global and composite), UW-QOL and Water Swallow Test scores. However, the improvements were found significantly hi... The Do-IMRT improves swallowing functions compared to S-IMRT in HNSCC patients treated with radical chemoradiation....

Humans Deglutition Disorders Radiotherapy, Intensity-Modulated Squamous Cell Carcinoma of Head and Neck Quality of Life +2 autres

Concurrent chemoradiotherapy versus radiotherapy alone for stage II nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.

Jul 2023

DOI: 10.1007/s00405-023-07943-9 PMID: 37079074

Concurrent chemoradiotherapy has long been a standardized therapy for localized advanced nasopharyngeal cancer. It is widely used in clinical applications. In contrast, NCCN guidelines highlight that ... We searched the relevant literature in PubMed, EMBASE, and Cochrane, extracting relevant data from the searched literature. The main items extracted were hazard ratios (HRs), risk ratios (RRs) and 95%... Our study included seven articles involving 1633 cases of stage II nasopharyngeal cancer. The survival outcomes were overall survival (OS) (HR = 1.03, 95% CI (0.71-1.49), P = 0.87), progression-free s... In the era of intensity-modulated radiotherapy, concurrent chemoradiotherapy and radiotherapy alone have the same survival benefits, and concurrent chemoradiotherapy increases acute hematological toxi...

Humans Nasopharyngeal Carcinoma Nasopharyngeal Neoplasms Radiotherapy, Intensity-Modulated Disease-Free Survival +3 autres

Is there a dosimetric advantage of volumetric modulated arc therapy over intensity modulated radiotherapy in head and neck cancer?

Nov 2022

DOI: 10.1007/s00405-022-07452-1 PMID: 35598230

A planning study was performed to evaluate dosimetric differences between intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) for head and neck cancer (HNC) for se... 30 patients with HNC were included, 15 treated with SIB and 15 with Seq-Boost. For all patients both VMAT and IMRT plans were completed. The planning objective for PTV was 95% of dose covering minimum... Both techniques achieved the set objectives regarding PTV coverage and organ sparing. SIB plans presented a statistically significant better homogeneity for VMAT (p = 0.0096), while Seq-boost showed a... VMAT shows dosimetric superiority to IMRT in some cases, however an adequate coverage of the target volumes and a suitable OAR sparing can be achieved with both techniques. Though IMRT is still the st...

Head and Neck Neoplasms Humans Radiometry Radiotherapy Dosage Radiotherapy Planning, Computer-Assisted +1 autres

Favorable outcome in advanced pheochromocytoma and paraganglioma after hypofractionated intensity modulated radiotherapy.

Mar 2023

DOI: 10.1007/s40618-022-01908-1 PMID: 36121637

The purpose of this study was to review outcomes of patients with advanced/metastatic pheochromocytoma/paraganglioma (PPGL) treated at our institution with Intensity-modulated radiotherapy (IMRT), des... A retrospective study on patients with advanced/metastatic PPGL who received IMRT at Peking Union Medical College Hospital between 2014 and 2019. A total of 14 patients with 17 lesions were included i... OS at 2 years was 78% for all patients. For lesions evaluated by RECIST response, at least stable disease of the target lesion was achieved in 94% and distant progression in 28.5%, with an average tim... We have found hypofractionated IMRT effective as an additional therapy for patients with advanced primary tumors or recurrence in situ and not amenable to complete surgical resection....

Humans Radiotherapy, Intensity-Modulated Pheochromocytoma Retrospective Studies Treatment Outcome +3 autres

Intensity-modulated radiotherapy for cushing's disease: single-center experience in 70 patients.

2023

DOI: 10.3389/fendo.2023.1241669 PMID: 37822603

Intensity-modulated radiotherapy (IMRT) is a modern precision radiotherapy technique for the treatment of the pituitary adenoma.... Aim to investigate the efficacy and toxicity of IMRT in treating Cushing's Disease (CD).... 70 of 115 patients with CD treated with IMRT at our institute from April 2012 to August 2021 were included in the study. The radiation doses were usually 45-50 Gy in 25 fractions. After IMRT, endocrin... At a median follow-up time of 36.8 months, the endocrine remission rate at 1, 2, 3 and 5 years were 28.5%, 50.2%, 62.5% and 74.0%, respectively. The median time to remission was 24 months (95%CI: 14.0... IMRT was a highly effective second-line therapy with low side effect profile for CD patients. Endocrine remission, tumor control and recurrence rates were comparable to previous reports on FRT and SRS...

Humans Pituitary ACTH Hypersecretion Radiotherapy, Intensity-Modulated Treatment Outcome Pituitary Neoplasms +1 autres

Patterns and prognosis of regional recurrence in nasopharyngeal carcinoma after intensity-modulated radiotherapy.

01 2023

DOI: 10.1002/cam4.5020 PMID: 35822664

We analyzed the patterns of lymph node (LN) failure and prognosis in patients with regional recurrent nasopharyngeal carcinoma (rNPC) alone after primary intensity-modulated radiotherapy (IMRT).... A total of 175 patients who were treated with IMRT between 2010 and 2015 and who experienced regional recurrence alone were included. Recurrent LNs were re-located in the initial pretreatment imaging ... Level IIb (49.1%, 86/175) was the most frequent recurrence site, followed by level IIa (36%), level III (18.9%), level IVa (12%), the retropharyngeal region (8%), level Va (6.9%), and the parotid regi... In-field failure represented the main pattern of regional recurrence and out-field failure mainly occurred in the parotid gland and level Ib. Patients with regional rNPC alone had a good prognosis aft...

Humans Nasopharyngeal Carcinoma Radiotherapy, Intensity-Modulated Nasopharyngeal Neoplasms Epstein-Barr Virus Infections +6 autres

Alveolata : Questions médicales fréquentes

Termes MeSH sélectionnés :

Questions fréquentes et termes MeSH associés

Diagnostic 5

Symptômes 5

Prévention 5

Traitements 5

Complications 5

Facteurs de risque 5

Contenu validé par Dr Olivier Menir

Sous-catégories

Apicomplexa

Ciliophora

Dinoflagellida

Coccidia

Haemosporida

Piroplasmia

Kinetofragminophorea

Oligohymenophorea

Polymenophorea

Pfiesteria piscicida

Eimeriida

Eucoccidiida

Plasmodium

Piroplasmida

Trichostomatida

Hymenostomatida

Hypotrichida

Cryptosporidiidae

Eimeriidae

Sarcocystidae

Plasmodium berghei

Plasmodium chabaudi

Plasmodium cynomolgi

Plasmodium falciparum

Plasmodium gallinaceum

Plasmodium knowlesi

Plasmodium malariae

Plasmodium ovale

Plasmodium vivax

Plasmodium yoelii

Babesia

Theileria

Trichostomatina

Peniculina

Tetrahymenina

Sporadotrichina

Cryptosporidium

Cyclospora

Eimeria

Isospora

Besnoitia

Neospora

Sarcocystis

Toxoplasma

Babesia bovis

Babesia microti

Theileria annulata

Theileria parva

Balantidium

Paramecium

Tetrahymena

Euplotes

Oxytricha

Cryptosporidium parvum

Eimeria tenella

Paramecium aurelia

Paramecium caudatum

Paramecium tetraurella

Tetrahymena pyriformis

Tetrahymena thermophila

Auteurs principaux

Sources (10000 au total)